ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
National automated surveillance of hospital onset bacteraemia and fungaemia using data from the national antimicrobial resistance surveillance system: a retrospective exploratory evaluation, the Netherlands, 2018 to 2023.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUNDHospital-onset bacteraemia and fungaemia (HOB) is a new target for automated surveillance of healthcare-associated infections.AIMWe aimed to evaluate (i) whether data from a national laboratory-based antimicrobial resistance (AMR) surveillance system (ISIS-AR) are a suitable source for fully automated HOB surveillance and (ii) whether the derived HOB rates from automated surveillance are a useful measure for national surveillance.METHODSWe applied an algorithm based on a consensus HOB definition to ISIS-AR data from 2018 to 2023. We performed: (i) technical evaluation of the data to determine their suitability for automated HOB surveillance, (ii) outcome validation of automatically identified HOB cases in four hospitals, and (iii) qualitative interviews with stakeholders on the anticipated value of HOB surveillance.RESULTSMost parameters required for HOB identification were present, except for hospital admission dates (≥ 80% available in only 14 hospitals). Outcome validation showed accurate identification of HOBs caused by pathogens (non-commensals), but identification of HOBs caused by common commensals varied between hospitals, reflecting laboratory policy differences. Interviewees emphasised that feedback from national HOB surveillance to hospitals can be valuable for monitoring local trends, as signal for in-depth investigations and benchmarking.CONCLUSIONDutch national automated HOB surveillance based on secondary use of national AMR surveillance data for pathogen-related HOBs is feasible, particularly if recording admission date is improved. Understanding local routine care and diagnostic practices is crucial for the interpretation of results. The main usefulness is expected at hospital level, while its value for national trend monitoring needs further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.